Magnus Lundberg

Magnus Lundberg discloses dealings in Onyx Pharmaceuticals Inc to SEC (Form 4). The record holds 17 filings, for trades running from 31 March 2009 to 1 October 2013.

Sales make up the whole of the open-market record (4 sales, €2.0M). Besides market trades, the filings include 7 share grants and 4 option exercises. Since January 2013: no purchases and 3 sales on the market.

Most recently, on 3 October 2013, the filings show a transaction worth €194k in Onyx Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.